98% up by HPLC, GMP,DMF,CEP Ezetimibe 163222-33-1

Name: 98% up by HPLC, GMP,DMF,CEP Ezetimibe 163222-33-1
Availability: 98-up-by-hplc-gmp-dmf-cep-ezetimibe-1632-276185.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:98% up by HPLC, GMP,DMF,CEP Ezetimibe 163222-33-1
CAS No.:163222-33-1
Standard:USP, BP, EP, JP, In-house Standards
Price(USD):Negotiable
Company:Sinoway Industrial Co. Ltd

Send Inquiry

Favorites

Product Information

Product name	Ezetimibe
CAS No.	163222-33-1
Molecular Formula	C24H21F2NO3
Molecular Weight	409.43
Quality Standard	98% up by HPLC, GMP,DMF,CEP
Appearance	White powder

COA of Ezetimibe

ITEMS	SPECIFICATION	RESULT
Appearance	White powder	Conforms
Specific rotation	-25.0。~ -29.0。	-26.2。
Melting range	160。C ~167。C	163。C~166。C
Identity	Retention time: Similar to Reference Substance	Conforms
Identity	IR: Similar to Reference Substance	Conforms
Chloride	≤ 0.01%	Conforms
Loss on drying	≤ 0.5%	0.11%
Sulphated Ash	≤ 0.1%	0.01%
Enantiomer	≤ 0.15%	Undetected
Diastereomer	≤ 0.15%	Undetected
Heavy metals	≤ 10 ppm	Conforms
Related substances	Single impurity ≤ 0.10% Total impurity ≤ 1.0%	0.06% 0.2%
Residual solvents	Methanol ≤ 3000ppm Isopropanol ≤ 5000ppm Chlorobenzene ≤ 360ppm	Undetected 351ppm Undetected
Assay	98.0～102.0%(calculated on the dried basis )	99.9%
Conclusion	The results above meet all requirements under Ezetimibe in In-House Standard.

Usage

Function of Ezetimibe

Ezetimibe is ananti-hyperlipidemic drug used for lowering the plasma cholesterol levels. It is indicated as an adjunctive therapy to diet for the reduction of high-level total-C, LDL-C, and ApoB in patients suffering primary (heterozygous familial and non-familial) hypercholesterolemia. It is also used in combination therapy with HMG-CoA reductase inhibitors.Ezetimibe does not inhibit the cholesterol synthesis in the liver, or increase bile acid excretion.Instead, ezetimibe takes effect throughacting at the brush border of the small intestine and inhibiting the absorption of cholesterol, further leading to a decrease in the delivery of intestinal cholesterol to the liver, This causes a reduction of hepatic cholesterol stores and an increase in clearance of blood cholesterol.

Send your message to this supplier

From:
To:
Sinoway Industrial Co. Ltd
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:


Please drag the slider to the right side





 help

Other Products from this supplier
More>>

NICOTINAMIDE MONONUCLEOTIDE (NMN) 1094-61-7

STEVIA LEAF EXTRACT 57817-89-7

L-GLUTATHIONE REDUCED (GSH) 70-18-8

NICOTINAMIDE ADENINE DINUCLEOTIDE 58-84-9

ALPHA GPC 28319-77-9

PALMITOYLETHANOLAMIDE (PEA) 544-31-0

PTEROSTILBENE 537-42-8

VONOPRAZAN FUMARATE 1260141-27-2

AZILSARTAN 147403-03-0

LOSARTAN POTASSIUM 124750-99-8

98% up by HPLC, GMP,DMF,CEP Ezetimibe 163222-33-1

Product Information

Product name

Ezetimibe

CAS No.

163222-33-1

Molecular Formula

C24H21F2NO3

Molecular Weight

409.43

Quality Standard